Market Overview:
The global wearable injector devices market is expected to grow at a CAGR of 10.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, technological advancements in wearable injector devices, and rising demand for minimally invasive procedures. Based on type, the global wearable injector devices market is segmented into disposable and reusable devices. The disposable segment is expected to account for a larger share of the market during the forecast period owing to its low cost and easy availability. Based on application, the global wearable injector devices market is segmented into oncology, diabetes, cardiovascular diseases, autoimmune disorder, infectious diseases, and others (including neurology disorders). The oncology segment is expected to account for a larger share of the market during the forecast period owing to rising incidence of cancer globally.
Product Definition:
A wearable injector device is a medical device that can be worn on the body to deliver medication or other treatments. These devices are often used to administer insulin or other medications to people with diabetes. They can also be used to deliver chemotherapy drugs, vaccines, and other treatments. The importance of wearable injector devices is that they allow people to receive treatment without having to go to a clinic or hospital. This allows them greater flexibility and independence in their lives.
Disposable:
Disposable medical devices are those products which are intended for single use and are designed to be discarded after a single function is performed. The global disposable injector devices market is expected to grow at a lucrative rate over the forecast period owing to factors such as increasing prevalence of chronic diseases, rising geriatric population base, growing healthcare awareness among people and government initiatives towards improving healthcare infrastructure in emerging economies.
Reusable:
Reusable injectors are medical devices used to deliver medication. They are mostly used in cases where a patient requires multiple doses of insulin for treating diabetes and require frequent injections. Reusable injectors can be single-use or multi-use devices depending on the type of diabetes treatment required by the patient.
Application Insights:
Oncology was the largest application segment in 2017 and is expected to maintain its dominance over the forecast period. This can be attributed to increasing cancer prevalence, which has resulted in growing demand for self-injecting devices. According to data published by WHO, it is estimated that globally around 1 in 6 women and 1 in 5 men are susceptible to developing cancer during their lifetime.
The infectious diseases segment is also expected register a notable CAGR owing to high unmet medical needs regarding treatment of chronic infections such as HIV/AIDS, tuberculosis & hepatitis among others. Furthermore, increasing incidences of drug-resistant bacteria and viruses will drive this segment further. Reusable devices offer better hygiene due to single use nature of disposable injectors which results into lesser contamination compared with reusable devices thus driving the market growth across various applications segments including diabetes mellitus type I & II, cardiovascular diseases (CVDs), auto immune disorders (AID), nephrological disease etcetera.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of industry players and increased adoption rate for advanced medical devices are some factors contributing to the growth. In addition, increasing healthcare expenditure by government and private sectors is also expected to drive the regional market over the forecast period. Asia Pacific is expected to grow at a lucrative CAGR during the forecast period owing to increasing disposable income levels, improving healthcare infrastructure facilities along with growing awareness about various treatment options available for chronic diseases in this region. Moreover, an increase in investments by key players for manufacturing wearable injector devices will boost growth further.
Growth Factors:
- Increasing demand for minimally invasive procedures: The global market for minimally invasive procedures is expected to reach $US252 billion by 2021, according to a MarketsandMarkets research study. This is due to the many benefits of these types of procedures, including shorter hospital stays, lower complication rates and quicker recoveries. Wearable injector devices offer an even more minimally invasive option than traditional methods and are likely to become increasingly popular as a result.
- Growing demand for targeted therapies: Cancer treatments that target specific tumor cells rather than whole organs are becoming increasingly common due to their improved efficacy and reduced side effects. Wearable injector devices can be used with such targeted therapies, providing patients with an easier way to receive treatment without having to go through surgery or other traditional methods.
- Advances in medical technology: The development of new medical technologies is always driving the growth of new markets and wearable injector devices are no exception. Recent advances in 3D printing technology have made it possible to create customized wearable injectors that perfectly fit the patient’s body shape and size, increasing comfort levels and usability while reducing the risk of complications or errors during treatment administration.. 4) Rising prevalence of chronic diseases: The incidence of chronic diseases such as cancer, diabetes mellitus and heart disease is on the rise globally due largelyto changing lifestylesand aging populations . These conditions often require long-term treatment regimens which can be administered using wearable injector devices for
Scope Of The Report
Report Attributes
Report Details
Report Title
Wearable Injector Devices Market Research Report
By Type
Disposable, Reusable
By Application
Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Disorder, Infectious Diseases, Others
By Companies
SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AGInsulet Corporation, Enable Injections, Becton, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd, SteadyMed Therapeutics, Inc., CeQur SA.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
217
Number of Tables & Figures
152
Customization Available
Yes, the report can be customized as per your need.
Global Wearable Injector Devices Market Report Segments:
The global Wearable Injector Devices market is segmented on the basis of:
Types
Disposable, Reusable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oncology, Diabetes, Cardiovascular Diseases, Autoimmune Disorder, Infectious Diseases, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- SteadyMed Therapeutics, Inc.
- UNILIFE CORPORATION
- Sensile Medical AGInsulet Corporation
- Enable Injections
- Becton
- West Pharmaceutical Services, Inc.
- Ypsomed
- Amgen
- Buhler Motor GmbH
- F. Hoffmann-La Roche Ltd
- SteadyMed Therapeutics, Inc.
- CeQur SA.
Highlights of The Wearable Injector Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Disposable
- Reusable
- By Application:
- Oncology
- Diabetes
- Cardiovascular Diseases
- Autoimmune Disorder
- Infectious Diseases
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Wearable Injector Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Wearable injector devices are medical devices that are worn on the body to deliver medications or other treatments. They can be attached to a belt, arm, or leg, and they use a small needle to inject the treatment directly into the body.
Some of the major players in the wearable injector devices market are SteadyMed Therapeutics, Inc., UNILIFE CORPORATION, Sensile Medical AGInsulet Corporation, Enable Injections, Becton, West Pharmaceutical Services, Inc., Ypsomed, Amgen, Buhler Motor GmbH, F. Hoffmann-La Roche Ltd, SteadyMed Therapeutics, Inc., CeQur SA..
The wearable injector devices market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Wearable Injector Devices Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Wearable Injector Devices Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Wearable Injector Devices Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Wearable Injector Devices Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Wearable Injector Devices Market Size & Forecast, 2018-2028
4.5.1 Wearable Injector Devices Market Size and Y-o-Y Growth
4.5.2 Wearable Injector Devices Market Absolute $ Opportunity
Chapter 5 Global Wearable Injector Devices Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Wearable Injector Devices Market Size Forecast by Type
5.2.1 Disposable
5.2.2 Reusable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Wearable Injector Devices Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Wearable Injector Devices Market Size Forecast by Applications
6.2.1 Oncology
6.2.2 Diabetes
6.2.3 Cardiovascular Diseases
6.2.4 Autoimmune Disorder
6.2.5 Infectious Diseases
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Wearable Injector Devices Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Wearable Injector Devices Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Wearable Injector Devices Analysis and Forecast
9.1 Introduction
9.2 North America Wearable Injector Devices Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Wearable Injector Devices Market Size Forecast by Type
9.6.1 Disposable
9.6.2 Reusable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Wearable Injector Devices Market Size Forecast by Applications
9.10.1 Oncology
9.10.2 Diabetes
9.10.3 Cardiovascular Diseases
9.10.4 Autoimmune Disorder
9.10.5 Infectious Diseases
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Wearable Injector Devices Analysis and Forecast
10.1 Introduction
10.2 Europe Wearable Injector Devices Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Wearable Injector Devices Market Size Forecast by Type
10.6.1 Disposable
10.6.2 Reusable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Wearable Injector Devices Market Size Forecast by Applications
10.10.1 Oncology
10.10.2 Diabetes
10.10.3 Cardiovascular Diseases
10.10.4 Autoimmune Disorder
10.10.5 Infectious Diseases
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Wearable Injector Devices Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Wearable Injector Devices Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Wearable Injector Devices Market Size Forecast by Type
11.6.1 Disposable
11.6.2 Reusable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Wearable Injector Devices Market Size Forecast by Applications
11.10.1 Oncology
11.10.2 Diabetes
11.10.3 Cardiovascular Diseases
11.10.4 Autoimmune Disorder
11.10.5 Infectious Diseases
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Wearable Injector Devices Analysis and Forecast
12.1 Introduction
12.2 Latin America Wearable Injector Devices Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Wearable Injector Devices Market Size Forecast by Type
12.6.1 Disposable
12.6.2 Reusable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Wearable Injector Devices Market Size Forecast by Applications
12.10.1 Oncology
12.10.2 Diabetes
12.10.3 Cardiovascular Diseases
12.10.4 Autoimmune Disorder
12.10.5 Infectious Diseases
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Wearable Injector Devices Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Wearable Injector Devices Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Wearable Injector Devices Market Size Forecast by Type
13.6.1 Disposable
13.6.2 Reusable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Wearable Injector Devices Market Size Forecast by Applications
13.10.1 Oncology
13.10.2 Diabetes
13.10.3 Cardiovascular Diseases
13.10.4 Autoimmune Disorder
13.10.5 Infectious Diseases
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Wearable Injector Devices Market: Competitive Dashboard
14.2 Global Wearable Injector Devices Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 SteadyMed Therapeutics, Inc.
14.3.2 UNILIFE CORPORATION
14.3.3 Sensile Medical AGInsulet Corporation
14.3.4 Enable Injections
14.3.5 Becton
14.3.6 West Pharmaceutical Services, Inc.
14.3.7 Ypsomed
14.3.8 Amgen
14.3.9 Buhler Motor GmbH
14.3.10 F. Hoffmann-La Roche Ltd
14.3.11 SteadyMed Therapeutics, Inc.
14.3.12 CeQur SA.
